Avandia MedGuide
Executive Summary
GlaxoSmithKline is alerting pharmacists and physicians about a new medication guide for the type 2 diabetes treatment Avandia. In accordance with advisory committee recommendations, FDA opted to keep Avandia (rosiglitazone) on the market following the emergence of a cardiovascular safety signal, but the agency expanded the "black box" warning and requested a long-term outcomes study to address its concerns